It also helps reduce visceral fat stores by promoting insulin sensitivity
Retatrutide and High Blood Pressure: Evidence, Cautions, and UK Guidance Retatrutide and high blood pressure is an emerging area of clinical interest, as this investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously has shown modest blood pressure reductions in early Phase 2 trials
Simultaneously, GLP-1s help manage the caloric intake needed to fuel these activities, ensuring that the body primarily taps into fat reserves
A recent systematic review stressed the need for larger, longer trials before drawing final conclusions
Despite the clear associations between habitual participation in RT and improved vascular and cerebrovascular function, the mechanisms as they relate to neurodegenerative disease such as ADRD have not been discussed
For best results, supplements should be used as part of a comprehensive health strategy including nutrition, lifestyle, and medical evaluation when appropriate
